Based on the immune‐associated prediction model, PCA showed a distinct subgroup and GSEA showed an enhanced local immune phenotype in high‐risk ccRCC patients, including enrichment of “natural killer cell mediated cytotoxicity” and “intestinal immune network for IgA production” pathways. Here, CD79A is linked to nonpapillary renal cell carcinoma.